Back to
Cerity Partners LLC
AMLX
Showing 1 of 2 quarters
Position history for
Cerity Partners LLC's holdings in Amylyx Pharmaceuticals, Inc.
No. Cerity Partners exited its AMLX (Amylyx Pharmaceuticals) position in Q3 2024. Its Q2 2024 13F listed 33,365 shares worth $63,394. Cerity Partners first reported AMLX in Q2 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History